938 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
AGN Allergan plc. $162.09 $53.54B Downtrend
Article Searches
Should You Follow Seth Klarman and David Tepper Into Allergan? http://www.gurufocus.com/news/644657/should-you-follow-seth-klarman-and-david-tepper-into-allergan Feb 21, 2018 - Should You Follow Seth Klarman and David Tepper Into Allergan?, Stocks: AGN, Seth Klarman, David Tepper, Wallace Weitz, release date:Feb 21, 2018
Muhlenkamp & Co. 4th Quarter 2017 Shareholder Letter http://www.gurufocus.com/news/644158/muhlenkamp--co-4th-quarter-2017-shareholder-letter Feb 21, 2018 - Muhlenkamp & Co. 4th Quarter 2017 Shareholder Letter, Stocks: AAPL,ON,OLED,TEVA,SAVE,AGN, release date:Feb 20, 2018
Tracking David Tepper's Appaloosa Management Portfolio - Q4 2017 Update https://seekingalpha.com/article/4148783-tracking-david-teppers-appaloosa-management-portfolio-q4-2017-update?source=feed_tag_editors_picks Feb 21, 2018 - David Tepper’s 13F portfolio value increased from $7.12B to $10.73B this quarter.Micron Technology is the largest individual stock position at ~11% of the portfolio.Appaloosa increased Micron Technolo
Teva's Problems Continue to Mount With No Relief in Sight http://www.zacks.com/stock/news/293077/tevas-problems-continue-to-mount-with-no-relief-in-sight?cid=CS-ZC-FT-293077 Feb 21, 2018 - Teva (TEVA) faces significant challenges including rapid erosion in sales of Copaxone and pricing erosion in the U.S. generics business.
Neurocrine Biosciences Shows Again That Sometimes The Tortoise Wins https://seekingalpha.com/article/4148380-neurocrine-biosciences-shows-sometimes-tortoise-wins?source=feed_sector_healthcare Feb 20, 2018 - Neurocrine's deliberate approach to pipeline development could lead to four drugs and six indications commercialized over the next four to five years, with multiple $1 billion-plus opportunities. Ingr
Tracking John Paulson's Paulson & Company Portfolio - Q4 2017 Update https://seekingalpha.com/article/4148207-tracking-john-paulsons-paulson-and-company-portfolio-q4-2017-update?source=feed_all_articles Feb 20, 2018 - John Paulson’s 13F portfolio value decreased from $5.57B to $5.12B this quarter.Paulson & Company's largest three positions are SPDR Gold ETF, Mylan NV, and Shire plc.Paulson increased Horizon Pharmac
Seth Klarman Buys Time Warner, Boosts Pioneer, Allergan http://www.gurufocus.com/news/643404/seth-klarman-buys-time-warner-boosts-pioneer-allergan Feb 19, 2018 - Seth Klarman Buys Time Warner, Boosts Pioneer, Allergan, Stocks: TWX,PXD,AGN,CAH,MCK,QRVO,ABC,FOXA, Seth Klarman, release date:Feb 19, 2018
Warren Buffett's Berkshire Claims $358 Million Investment In Teva, But That Doesn't Change The Final Outcome https://seekingalpha.com/article/4148107-warren-buffetts-berkshire-claims-358-million-investment-teva-change-final-outcome?source=feed_sector_healthcare Feb 19, 2018 - Berkshire Hathaway has made an investment in Teva for $358 million, but that doesn't fix any of the company's issues at hand.Earnings have continued to decline year over year, despite Teva's attempt t
Allergan PLC (AGN) Files 10-K for the Fiscal Year Ended on December 31, 2017 http://www.gurufocus.com/news/642825/allergan-plc-agn-files-10k-for-the-fiscal-year-ended-on-december-31-2017 Feb 16, 2018 - Allergan PLC (AGN) Files 10-K for the Fiscal Year Ended on December 31, 2017, Stocks: AGN, release date:Feb 16, 2018
Ironwood (IRWD) Beats Estimates in Q4 Earnings, Stock Up http://www.zacks.com/stock/news/292704/ironwood-irwd-beats-estimates-in-q4-earnings-stock-up?cid=CS-ZC-FT-292704 Feb 16, 2018 - Ironwood Pharmaceuticals (IRWD) beats estimates on both counts in the fourth quarter. Demand for Linzess continues to rise.

Pages: 1234567...94

<Page 2>